![Ken Macnamara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Macnamara
Directeur des opérations chez Synpromics Ltd.
Postes actifs de Ken Macnamara
Sociétés | Poste | Début | Fin |
---|---|---|---|
Synpromics Ltd.
![]() Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Directeur des opérations | - | - |
Asklepios BioPharmaceutical, Inc.
![]() Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Directeur des opérations | 01/01/2019 | - |
Historique de carrière de Ken Macnamara
Statistiques
Internationale
Royaume-Uni | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Operating Officer | 2 |
Sectorielle
Process Industries | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Synpromics Ltd.
![]() Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Process Industries |
Asklepios BioPharmaceutical, Inc.
![]() Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Ken Macnamara
- Expérience